Evidence map›Paper›PMID 35953772›Full record

ArticleBMC infectious diseases2022

The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults.

Elske Sieswerda, Hannelore I Bax, Jacobien J Hoogerwerf, Mark G J de Boer, Marja Boermeester, Marc J M Bonten, Douwe Dekker, Roy Gerth van Wijk, Nicole P Juffermans, Marnix Kuindersma and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05750966 (Very Short-course Versus Standard Course Antibiotic Therapy in Patients With Acute ChOlangitis After Adequate Endoscopic BiliaRy drAinage), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05750966 nacompletednot on this mapstarted 2023, after this paper: background citation

Very Short-course Versus Standard Course Antibiotic Therapy in Patients With Acute ChOlangitis After Adequate Endoscopic BiliaRy drAinage

TypeinterventionalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2023 to 2026Enrolled410ConditionsCholangitisArmscefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (24 hours), cefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (4 to 7 days)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Validation of CRownLab Pneumoplex for the Detection ofInternational journal of microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 1 country.

Elske SieswerdaDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands. e.sieswerda@umcutrecht.nl.
Hannelore I BaxDepartment of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jacobien J HoogerwerfDepartment of Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Mark G J de BoerDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Marja BoermeesterDepartment of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Marc J M BontenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Douwe DekkerDepartment of Internal Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
Roy Gerth van WijkDivision of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Nicole P JuffermansDepartment of Intensive Care, OLVG Hospital, Amsterdam, The Netherlands.
Marnix KuindersmaDepartment of Intensive Care, Gelre ziekenhuis Apeldoorn, Apeldoorn, The Netherlands.
Paul D van der LindenDepartment of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
Damian C MellesDepartment of Medical Microbiology and Immunology, Meander Medical Center, Amersfoort, The Netherlands.
Peter PickkersDepartment of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen A SchoutenDepartment of Intensive Care Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Jasper R RebelDepartment of Emergency Medicine, OLVG Hospital, Amsterdam, The Netherlands.
Arthur R H van ZantenDepartment of Intensive Care Medicine, Ziekenhuis Gelderse Vallei, Ede, The Netherlands.
Jan M PrinsDivision of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
W Joost WiersingaDivision of Infectious Diseases, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLErasmus MC · NLOLVG · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLGelre Hospitals · NLLeiden University Medical Center · NLMeander Medisch Centrum · NLRadboud University Medical Center · NLTergooi · NLUniversity of Amsterdam · NLUtrecht University · NLZiekenhuis Gelderse Vallei · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults.

methodsOur multidisciplinary guideline committee generated ten population, intervention, comparison, and outcome (PICO) questions relevant for adult patients with sepsis. For each question, a literature search was performed to obtain the best available evidence and assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The quality of evidence for clinically relevant outcomes was graded from high to very low. In structured consensus meetings, the committee formulated recommendations as strong or weak. When evidence could not be obtained, recommendations were provided based on expert opinion and experience (good practice statements).

resultsFifty-five recommendations on the antibacterial therapy of sepsis were generated. Recommendations on empiric antibacterial therapy choices were differentiated for sepsis according to the source of infection, the potential causative pathogen and its resistance pattern. One important revision was the distinction between low, increased and high risk of infection with Enterobacterales resistant to third generation cephalosporins (3GRC-E) to guide the choice of empirical therapy. Other new topics included empirical antibacterial therapy in patients with a reported penicillin allergy and the role of pharmacokinetics and pharmacodynamics to guide dosing in sepsis. We also established recommendations on timing and duration of antibacterial treatment.

conclusionsOur multidisciplinary committee formulated evidence-based recommendations for the empiric antibacterial therapy of adults with sepsis in The Netherlands.

Indexed as

Anti-Bacterial AgentsSepsisAdultHumansNetherlandsPolicyAnti-Bacterial AgentsAntibacterial therapyAntimicrobial resistanceDuration of antibiotic therapyEmpirical therapyEnterobacteralesGuidelinesPenicillin allergyPharmacodynamicsPharmacokineticsPseudomonas aeruginosaSepsis

Identifiers

PMID35953772
PMCPMC9373543
OpenAlexW4290804030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.